Evaluation of TACE combined with gamma-knife radiotherapy for primary hepatocellular carcinoma

Journal of Interventional Radiology (China)

Volumn 21, Issue 7, 2012, Pages 596-599

  Zhang, Zhi Liang ^a   Yang, Xue Dong ^a   Wen, A Ming ^a   Wan, Jun Ping ^a  

^a No 411 Hospital of PLA   (China)

Author keywords

Gamma knife; Primary hepatocellular carcinoma; Transcatheter arterial chemoembolization

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; GAMMA KNIFE RADIOTHERAPY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84867413051     PISSN: 1008794X     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-794X.2012.07.17     Document Type: Article

References (8)

1. Choi BO, Jang HS, Kang KM, et al. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma [J]. Jpn J Clin Oncol, 2006,36:154-158.
2. Kwon JH, Bae SH, Kim JY, et al. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer[J]. BMC Cancer, 2010, 10:475.